185 related articles for article (PubMed ID: 33249148)
1. Synthesis of novel superdisintegrants for pharmaceutical tableting based on functionalized nanocellulose hydrogels.
Sheikhy S; Safekordi AA; Ghorbani M; Adibkia K; Hamishehkar H
Int J Biol Macromol; 2021 Jan; 167():667-675. PubMed ID: 33249148
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of a novel superdisintegrant by starch derivatization with polysuccinimide and its application for the development of Ondansetron fast dissolving tablet.
Sadeghi M; Hemmati S; Hamishehkar H
Drug Dev Ind Pharm; 2016; 42(5):769-75. PubMed ID: 26289005
[TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of nanocrystalline cellulose as a potential disintegrant.
Wang C; Huang H; Jia M; Jin S; Zhao W; Cha R
Carbohydr Polym; 2015 Oct; 130():275-9. PubMed ID: 26076627
[TBL] [Abstract][Full Text] [Related]
4. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
Lin SY; Lin KH; Li MJ
J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of a novel superdisintegrant by starch derivatization with polysuccinimide and its application for the development of Ondansetron fast dissolving tablet.
Sadeghi M; Hemmati S; Hamishehkar H
Drug Dev Ind Pharm; 2016 May; 42(5):769-775. PubMed ID: 26275030
[TBL] [Abstract][Full Text] [Related]
6. Development of polymer-bound fast-dissolving metformin buccal film with disintegrants.
Haque SE; Sheela A
Int J Nanomedicine; 2015; 10 Suppl 1(Suppl 1):199-205. PubMed ID: 26491321
[TBL] [Abstract][Full Text] [Related]
7. Role of wetting agents and disintegrants in development of danazol nanocrystalline tablets.
Meruva S; Thool P; Gong Y; Karki S; Bowen W; Kumar S
Int J Pharm; 2020 Mar; 577():119026. PubMed ID: 31940456
[TBL] [Abstract][Full Text] [Related]
8. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
[TBL] [Abstract][Full Text] [Related]
9. The Disintegration Process in Microcrystalline Cellulose Based Tablets, Part 1: Influence of Temperature, Porosity and Superdisintegrants.
Yassin S; Goodwin DJ; Anderson A; Sibik J; Wilson DI; Gladden LF; Zeitler JA
J Pharm Sci; 2015 Oct; 104(10):3440-50. PubMed ID: 26073446
[TBL] [Abstract][Full Text] [Related]
10. Surface dissolution UV imaging for characterization of superdisintegrants and their impact on drug dissolution.
Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
Int J Pharm; 2020 Mar; 577():119080. PubMed ID: 31988030
[TBL] [Abstract][Full Text] [Related]
11. Application of silicified microcrystalline cellulose (Prosolv) as a polymer carrier of Epilobium parviflorum Schreb. extract in oral solid drug form.
Marczyński Z; Zgoda MM; Jambor J
Polim Med; 2007; 37(2):21-32. PubMed ID: 17957946
[TBL] [Abstract][Full Text] [Related]
12. Formulation and in vitro Evaluation of Fast Dissolving Tablets of Febuxostat Using Co-Processed Excipients.
Kaur M; Mittal A; Gulati M; Sharma D; Kumar R
Recent Pat Drug Deliv Formul; 2020; 14(1):48-62. PubMed ID: 31884935
[TBL] [Abstract][Full Text] [Related]
13. Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma.
Chen YD; Liang ZY; Cen YY; Zhang H; Han MG; Tian YQ; Zhang J; Li SJ; Yang DS
Drug Des Devel Ther; 2015; 9():5815-25. PubMed ID: 26640367
[TBL] [Abstract][Full Text] [Related]
14. Functionality of disintegrants and their mixtures in enabling fast disintegration of tablets by a quality by design approach.
Desai PM; Er PX; Liew CV; Heng PW
AAPS PharmSciTech; 2014 Oct; 15(5):1093-104. PubMed ID: 24848762
[TBL] [Abstract][Full Text] [Related]
15. Drug release from nanoparticles embedded in four different nanofibrillar cellulose aerogels.
Valo H; Arola S; Laaksonen P; Torkkeli M; Peltonen L; Linder MB; Serimaa R; Kuga S; Hirvonen J; Laaksonen T
Eur J Pharm Sci; 2013 Sep; 50(1):69-77. PubMed ID: 23500041
[TBL] [Abstract][Full Text] [Related]
16. Development of modified-release tablets of zolpidem tartrate by biphasic quick/slow delivery system.
Mahapatra AK; Sameeraja NH; Murthy PN
AAPS PharmSciTech; 2015 Jun; 16(3):579-88. PubMed ID: 25391273
[TBL] [Abstract][Full Text] [Related]
17. The influence of ethanol on superdisintegrants and on tablets disintegration.
Bisharat L; AlKhatib HS; Muhaissen S; Quodbach J; Blaibleh A; Cespi M; Berardi A
Eur J Pharm Sci; 2019 Mar; 129():140-147. PubMed ID: 30630089
[TBL] [Abstract][Full Text] [Related]
18. Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs.
Zaheer K; Langguth P
Eur J Pharm Biopharm; 2019 Jun; 139():177-185. PubMed ID: 30902732
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous investigation of the liquid transport and swelling performance during tablet disintegration.
Al-Sharabi M; Markl D; Mudley T; Bawuah P; Karttunen AP; Ridgway C; Gane P; Ketolainen J; Peiponen KE; Rades T; Zeitler JA
Int J Pharm; 2020 Jun; 584():119380. PubMed ID: 32407939
[TBL] [Abstract][Full Text] [Related]
20. Experimental Design for Determination of Effects of Superdisintegrant Combinations on Liquisolid System Properties.
Vraníková B; Pavloková S; Gajdziok J
J Pharm Sci; 2017 Mar; 106(3):817-825. PubMed ID: 27923491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
